Axsome Therapeutics (AXSM) Profit After Tax Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn | -8.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.63% |
| Dec 31, 2025 | 61.88% |
| Sep 30, 2025 | 26.89% |
| Jun 30, 2025 | 39.54% |
| Mar 31, 2025 | 13.08% |
| Dec 31, 2024 | 24.06% |
| Sep 30, 2024 | -3.86% |
| Jun 30, 2024 | -18.13% |
| Mar 31, 2024 | -509.35% |
| Dec 31, 2023 | -61.09% |
| Sep 30, 2023 | -38.77% |
| Jun 30, 2023 | -62.09% |
| Mar 31, 2023 | 71.69% |
| Dec 31, 2022 | -80.25% |
| Sep 30, 2022 | -28.50% |
| Jun 30, 2022 | -28.36% |
| Mar 31, 2022 | -35.45% |
| Dec 31, 2021 | -16.50% |
| Sep 30, 2021 | -52.16% |
| Jun 30, 2021 | -76.16% |
| Mar 31, 2021 | 9.93% |
| Dec 31, 2020 | -17.57% |
| Sep 30, 2020 | -19.80% |
| Jun 30, 2020 | -33.17% |
| Mar 31, 2020 | -205.29% |
| Dec 31, 2019 | -158.49% |
| Sep 30, 2019 | -131.05% |
| Jun 30, 2019 | -66.19% |
| Mar 31, 2019 | -121.42% |
| Dec 31, 2018 | -29.16% |
| Sep 30, 2018 | -28.73% |
| Jun 30, 2018 | -16.89% |
| Mar 31, 2018 | 39.89% |
| Dec 31, 2017 | -1.39% |
| Sep 30, 2017 | 10.58% |
| Jun 30, 2017 | -3.99% |
| Mar 31, 2017 | -36.30% |
| Dec 31, 2016 | -117.80% |
| Sep 30, 2016 | -57.22% |
| Jun 30, 2016 | -219.91% |
| Mar 31, 2016 | -174.09% |